Literature DB >> 20818174

Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism.

Gloria Bonuccelli1, Aristotelis Tsirigos, Diana Whitaker-Menezes, Stephanos Pavlides, Richard G Pestell, Barbara Chiavarina, Philippe G Frank, Neal Flomenberg, Anthony Howell, Ubaldo E Martinez-Outschoorn, Federica Sotgia, Michael P Lisanti.   

Abstract

Previously, we proposed a new model for understanding the "Warburg effect" in tumor metabolism. In this scheme, cancer-associated fibroblasts undergo aerobic glycolysis and the resulting energy-rich metabolites are then transferred to epithelial cancer cells, where they enter the TCA cycle, resulting in high ATP production via oxidative phosphorylation. We have termed this new paradigm "The Reverse Warburg Effect." Here, we directly evaluate whether the end-products of aerobic glycolysis (3-hydroxy-butyrate and L-lactate) can stimulate tumor growth and metastasis, using MDA-MB-231 breast cancer xenografts as a model system. More specifically, we show that administration of 3-hydroxy-butyrate (a ketone body) increases tumor growth by ∼2.5-fold, without any measurable increases in tumor vascularization/angiogenesis. Both 3-hydroxy-butyrate and L-lactate functioned as chemo-attractants, stimulating the migration of epithelial cancer cells. Although L-lactate did not increase primary tumor growth, it stimulated the formation of lung metastases by ∼10-fold. Thus, we conclude that ketones and lactate fuel tumor growth and metastasis, providing functional evidence to support the "Reverse Warburg Effect". Moreover, we discuss the possibility that it may be unwise to use lactate-containing i.v. solutions (such as Lactated Ringer's or Hartmann's solution) in cancer patients, given the dramatic metastasis-promoting properties of L-lactate. Also, we provide evidence for the up-regulation of oxidative mitochondrial metabolism and the TCA cycle in human breast cancer cells in vivo, via an informatics analysis of the existing raw transcriptional profiles of epithelial breast cancer cells and adjacent stromal cells. Lastly, our findings may explain why diabetic patients have an increased incidence of cancer, due to increased ketone production, and a tendency towards autophagy/mitophagy in their adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20818174      PMCID: PMC3047616          DOI: 10.4161/cc.9.17.12731

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  53 in total

1.  Metastatic reticulum cell sarcoma and lactic acidosis.

Authors:  R G Kachel
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

2.  Lactic acidosis in oat cell carcinoma with extensive hepatic metastases.

Authors:  G Wesbey
Journal:  Arch Intern Med       Date:  1981-05

3.  Lactic acidosis associated with metastatic osteogenic sarcoma.

Authors:  P W Stacpoole; M J Lichtenstein; J R Polk; F A Greco
Journal:  South Med J       Date:  1981-07       Impact factor: 0.954

4.  Disseminated intravascular coagulation: experience in a major cancer center.

Authors:  H Al-Mondhiry
Journal:  Thromb Diath Haemorrh       Date:  1975-09-30

5.  Inhibition of lactate transport and glycolysis in Ehrlich ascites tumor cells by bioflavonoids.

Authors:  J A Belt; J A Thomas; R N Buchsbaum; E Racker
Journal:  Biochemistry       Date:  1979-08-07       Impact factor: 3.162

6.  Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation.

Authors:  Stephanos Pavlides; Aristotelis Tsirigos; Iset Vera; Neal Flomenberg; Philippe G Frank; Mathew C Casimiro; Chenguang Wang; Paolo Fortina; Sankar Addya; Richard G Pestell; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-06-01       Impact factor: 4.534

7.  Lactic acidosis associated with metastatic breast carcinoma.

Authors:  U R Varanasi; B Carr; D P Simpson
Journal:  Cancer Treat Rep       Date:  1980

8.  Lactic acidosis in lung cancer.

Authors:  R N Raju; C G Kardinal
Journal:  South Med J       Date:  1983-03       Impact factor: 0.954

Review 9.  The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism.

Authors:  Richard L Veech
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-03       Impact factor: 4.006

Review 10.  Ketoacids? Good medicine?

Authors:  George F Cahill; Richard L Veech
Journal:  Trans Am Clin Climatol Assoc       Date:  2003
View more
  258 in total

Review 1.  The autophagic tumor stroma model of cancer or "battery-operated tumor growth": A simple solution to the autophagy paradox.

Authors:  Ubaldo E Martinez-Outschoorn; Diana Whitaker-Menezes; Stephanos Pavlides; Barbara Chiavarina; Gloria Bonuccelli; Trimmer Casey; Aristotelis Tsirigos; Gemma Migneco; Agnieszka Witkiewicz; Renee Balliet; Isabelle Mercier; Chengwang Wang; Neal Flomenberg; Anthony Howell; Zhao Lin; Jaime Caro; Richard G Pestell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-11-30       Impact factor: 4.534

Review 2.  Lipid Metabolism in Tumor-Associated Fibroblasts.

Authors:  Hongzhong Li; Jingyuan Wan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  A small molecule with anticancer and antimetastatic activities induces rapid mitochondrial-associated necrosis in breast cancer.

Authors:  Anja Bastian; Jessica E Thorpe; Bryan C Disch; Lora C Bailey-Downs; Aleem Gangjee; Ravi K V Devambatla; Jim Henthorn; Kenneth M Humphries; Shraddha S Vadvalkar; Michael A Ihnat
Journal:  J Pharmacol Exp Ther       Date:  2015-02-26       Impact factor: 4.030

Review 4.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

Review 5.  Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence.

Authors:  Sarah Crawford
Journal:  Ther Adv Med Oncol       Date:  2014-03       Impact factor: 8.168

Review 6.  Including the mitochondrial metabolism of L-lactate in cancer metabolic reprogramming.

Authors:  Lidia de Bari; Anna Atlante
Journal:  Cell Mol Life Sci       Date:  2018-05-04       Impact factor: 9.261

7.  Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metformin.

Authors:  Rosa Sanchez-Alvarez; Ubaldo E Martinez-Outschoorn; Rebecca Lamb; James Hulit; Anthony Howell; Ricardo Gandara; Marina Sartini; Emanuel Rubin; Michael P Lisanti; Federica Sotgia
Journal:  Cell Cycle       Date:  2012-12-20       Impact factor: 4.534

8.  Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention.

Authors:  Rosa Sanchez-Alvarez; Ubaldo E Martinez-Outschoorn; Zhao Lin; Rebecca Lamb; James Hulit; Anthony Howell; Federica Sotgia; Emanuel Rubin; Michael P Lisanti
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

9.  Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review).

Authors:  Jie Zheng
Journal:  Oncol Lett       Date:  2012-09-20       Impact factor: 2.967

10.  Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme.

Authors:  Arnulf Mayer; Peter Vaupel; Hans-Garlich Struss; Alf Giese; Marcus Stockinger; Heinz Schmidberger
Journal:  Strahlenther Onkol       Date:  2014-06-18       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.